Select Medical acquisition frames the debate here: As the healthcare landscape continues to evolve, the recent approval of the acquisition of Select Medical Holdings Corporation by a consortium led by Robert A. Ortenzio, Martin F. Jackson, and WCAS is a significant development that warrants attention, particularly in light of the company’s history and the implications for the industry, under the watchful eye of Select Medical.
The announcement, made on June 26, 2026, via PRNewswire, confirms that the stockholders of Select Medical have given their approval for the acquisition, paving the way for a new chapter in the company’s history. According to the press release, the Merger Agreement has been a subject of interest for stakeholders, who are now looking forward to seeing how this change in ownership will impact the company’s operations and services.
Given the context of the current healthcare market, this acquisition is likely to have far-reaching consequences, not just for Select Medical but also for its patients, employees, and the broader healthcare community. The consortium, led by experienced leaders in the field, brings a wealth of knowledge and resources to the table, which could potentially drive innovation and improvement in the services provided by Select Medical.
What landed
The strongest moment in the announcement was the confirmation of stockholder approval, which marks a significant milestone in the acquisition process, as reported by PRNewswire. This development suggests that the stakeholders are aligned with the vision of the consortium and are willing to move forward with the merger. Robert A. Ortenzio and Martin F. Jackson, as part of the consortium, are expected to bring their expertise to the forefront, guiding Select Medical towards a new era of growth and development. The fact that the acquisition has received approval from the stockholders indicates a level of trust in the consortium’s ability to lead the company forward, as stated in the press release.
The announcement also highlights the potential benefits of the acquisition, including the possibility of enhanced services and improved patient care. As the consortium takes the reins, it is expected that they will leverage their experience and resources to drive positive change within Select Medical. This could involve investments in new technologies, expansion of services, and a renewed focus on patient-centric care. According to the Merger Agreement, the acquisition is expected to be completed in the coming months, subject to regulatory approvals and other customary closing conditions.

What doesn’t add up
One aspect that does not entirely add up is the lack of detailed information regarding the consortium’s long-term plans for Select Medical. While the announcement provides a general overview of the acquisition and the approval process, it does not delve deeply into the strategic vision of the consortium. This lack of transparency may raise questions among stakeholders and observers, who are eager to understand how the change in ownership will impact the company’s operations and services. Furthermore, the press release does not provide explicit details on how the acquisition will affect the company’s employees, which could be a point of concern for those directly impacted by the change in ownership.
The acquisition of Select Medical by the consortium is a complex process, and as such, it is natural to have some unanswered questions. However, as the process moves forward, it is essential that the consortium provides clear and concise information about their plans and vision for the company. This will not only alleviate concerns among stakeholders but also demonstrate a commitment to transparency and open communication. As reported by PRNewswire, the company will continue to operate under its current name and leadership structure until the acquisition is completed.
As the dust settles on this significant development, one thing is clear: the acquisition of Select Medical Holdings Corporation by the consortium led by Robert A. Ortenzio, Martin F. Jackson, and WCAS marks a new chapter in the company’s history. The stakes are high, and the outcome will be closely watched by industry observers, patients, and employees alike. Come Monday morning, the real work begins, as the consortium sets out to implement their vision for Select Medical, and the world waits to see how this change in ownership will shape the future of healthcare.


That tension around Select Medical acquisition is not going away.
Source: OnTheRecord
